Risk factors for age-related maculopathy: The visual impairment project

Archives of Ophthalmology

Volumn 119, Issue 10, 2001, Pages 1455-1462

  McCarty, C A ^a   Mukesh, B N ^a   Fu, C L ^a   Mitchell, P ^a   Jie Jin Wang, ^a   Taylor, H R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; AUSTRALIA; CIGARETTE SMOKING; DIETARY INTAKE; EYE FUNDUS; FAMILY HISTORY; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; RURAL POPULATION; SUNLIGHT; URBAN POPULATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 0034800657     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.119.10.1455     Document Type: Article

References (63)

1. The prevalence of age-related maculopathy: The visual impairment project
2. Visual acuity and the causes of visual loss in Australia: The Blue Mountains Eye Study
3. The Framingham Eye Study, II: Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study
4. Senile macular degeneration and risk factors: A case-control study
5. Senile macular degeneration: A case-control study
6. Factors associated with age-related macular degeneration: An analysis of data from the first National Health and Nutrition Examination Survey
7. Risk factors for neovascular age-related macular degeneration
8. Risk factors of age-related maculopathy in a population 70 years of age or older
9. Case-control study of the risk factors for age-related macular degeneration
10. Is genetic predisposition an important risk factor in age-related macular degeneration?
11. Sibling correlations and segregation analysis of age-related maculopathy: The Beaver Dam Eye Study
12. A twin study of age-related macular degeneration
13. Familial aggregation of age-related maculopathy
14. Family history and age-related maculopathy: The Blue Mountains Eye Study
15. Age-related macular degeneration: Clinical features in a large family and linkage to chromosome 1 q
16. Hyperopia and neo-vascularization in age-related macular degeneration
17. Refractive error and age-related maculopathy: The Blue Mountains Eye Study
18. Iris pigmentation and extent of eye disease in patients with neovascular age-related macular degeneration
19. Iris color, skin sun sensitivity, and age-related maculopathy
20. Systemic hypertension and age-related maculopathy in the Framingham Study
21. The relationship of cardiovascular disease and its risk factors to age-related maculopathy: The Beaver Dam Eye Study
22. Age-related macular degeneration is associated with atherosclerosis: The Rotterdam Study
23. The Beaver Dam Eye Study: The relation of age-related maculopathy to smoking
24. A prospective study of cigarette smoking and age-related macular degeneration in women
25. A prospective study of cigarette smoking and risk of age-related macular degeneration in men
26. Smoking and age-related maculopathy: The Blue Mountains Eye Study
27. Age-related macular degeneration and smoking: The Rotterdam Study
28. Smoking is also associated with age-related macular degeneration in persons aged 85 years and older: The Rotterdam Study
29. Smoking and age-related macular degeration: The POLA Study
30. Alcohol use and age-related maculopathy in the Beaver Dam Eye Study
31. Alcohol intake and age-related maculopathy
32. Exposure to sunlight and other risk factors for age-related macular degeneration
33. Sunlight and age-related macular degeneration: The Beaver Dam Eye Study
34. Sun exposure and age-related macular degeneration: An Australian case-control study
35. Antioxidant status and neovascular age-related macular degeneration
36. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration
37. Are antioxidants or supplements protective for age-related macular degeneration?
38. Serum antioxidants and age-related macular degeneration in a population-based case-control study
39. Association of zinc and antioxidant nutrients with age-related maculopathy
40. Smoking is a major cause of blindness
41. Methods for a population-based study of eye disease: The Melbourne Visual Impairment Project
42. Reliability of a food frequency questionnaire to assess dietary antioxidant intake
43. Ocular exposure to UV-B in sunlight: The Melbourne Visual Impairment Project model
44. Visible and ultraviolet-B ocular-ambient exposure ratios for a general population
45. The effect of sunglasses on ocular exposure to ultraviolet radiation
46. The Wisconsin age-related maculopathy grading system
47. An international classification and grading system for age-related maculopathy and age-related macular degeneration
48. Epidemiologic investigation of occupational carcinogenesis using a serially additive expected dose model
49. Estimating the population attributable risk for multiple risk factors using case-control data
50. A comparison of participants with non-participants in a population-based epidemiologic study: The Melbourne Visual Impairment Project
51. Risk factors for age-related macular degeneration: Pooled findings from three continents
52. Gender, oestrogen, hormone, replacement therapy and age-related macular degeneration: Results from the Blue Mountains Eye Study
53. Is age-related maculopathy associated with cataracts?
54. Lens opacities and senile maculopathy
55. The relationship of ocular factors to the incidence and progression of age-related maculopathy
56. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy
57. Risk factors in age-related maculopathy complicated by choroidal neovascularization
58. Serum levels of antioxidants and age-related macular degeneration
59. Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects
60. Dietary antioxidants and age-related maculopathy: The Blue Mountains Eye Study
61. Methodology of the VECAT Study: Vitamin E intervention in cataract and age-related maculopathy
62. Baseline ophthalmic findings in the Vitamin E, Cataract and Age-Related Maculopathy (VECAT) study
63. The Age-Related Eye Disease Study (AREDS): Design implications: AREDS report No. 1